Advertisement
Screener

HCA Healthcare, Inc. (HCA) Executive Pay versus Performance: Pay versus Performance

HCA Healthcare, Inc. Pay versus Performance

The Pay versus Performance table from each proxy statement (Item 402(v)), as tagged in its XBRL, newest proxy first. Each proxy's own figures are kept, so a year restated in a later proxy appears once per proxy. PEO is the principal executive officer; NEO means the other named executive officers (average). Total shareholder return is the value of a $100 investment.

  • 2025-12-31: PEO Hazen; PEO total compensation $26.46M; PEO compensation actually paid $78.24M; Other NEO average total compensation $8.19M.
  • 2024-12-31: PEO total compensation $23.80M; PEO compensation actually paid $40.15M; Other NEO average total compensation $6.12M.
  • 2023-12-31: PEO total compensation $21.32M; PEO compensation actually paid $23.59M; Other NEO average total compensation $6.86M.
  • 2022-12-31: PEO total compensation $14.64M; PEO compensation actually paid $9.58M; Other NEO average total compensation $5.17M.
Fiscal year endPEOPEO total compensationPEO compensation actually paidOther NEO average total compensationOther NEO average compensation actually paidTotal shareholder returnPeer group total shareholder returnNet incomeCompany-selected measureProxy filed
2025-12-31Hazen$26.46M$78.24M$8.19M$16.38M$296.34$148.36$6.78BAdjusted EBITDA
$15.57B
2026-03-13
2024-12-31$23.80M$40.15M$6.12M$6.09M$189.11$129.46$5.76B$13.88B2026-03-13
2023-12-31$21.32M$23.59M$6.86M$7.05M$169.23$126.21$5.24B$12.73B2026-03-13
2022-12-31$14.64M$9.58M$5.17M$3.41M$148.69$123.67$5.64B$12.07B2026-03-13
2021-12-31$20.64M$84.57M$6.00M$19.63M$157.59$126.13$6.96B$12.64B2026-03-13
2024-12-31Hazen$23.80M$40.15M$6.12M$6.09M$211.12$146.87$5.76BAdjusted EBITDA
$13.88B
2025-03-14
2023-12-31$21.32M$23.59M$6.86M$7.05M$188.93$143.18$5.24B$12.73B2025-03-14
2022-12-31$14.64M$9.58M$5.17M$3.41M$165.99$140.29$5.64B$12.07B2025-03-14
2021-12-31$20.64M$84.57M$6.00M$19.63M$175.93$143.09$6.96B$12.64B2025-03-14
2020-12-31$30.40M$30.45M$7.04M$7.88M$111.64$113.45$3.75B$10.04B2025-03-14
2023-12-31Hazen$21.32M$23.59M$6.86M$7.05M$188.93$143.18$5.24BAdjusted EBITDA
$12.73B
2024-03-15
2022-12-31$14.64M$9.58M$5.17M$3.41M$165.99$140.29$5.64B$12.07B2024-03-15
2021-12-31$20.64M$84.57M$6.00M$19.63M$175.93$143.09$6.96B$12.64B2024-03-15
2020-12-31$30.40M$30.45M$7.04M$7.88M$111.64$113.45$3.75B$10.04B2024-03-15
2022-12-31Hazen$14.64M$8.49M$5.17M$3.22M$165.99$140.29$5.64BAdjusted EBITDA
$120.67M
2023-03-10
2021-12-31$20.64M$85.06M$6.00M$19.83M$175.93$143.09$6.96B$126.44M2023-03-10
2020-12-31$30.40M$30.53M$7.04M$7.91M$111.64$113.45$3.75B$100.37M2023-03-10

Similar stocks

Stock NameCountryMarket CapPE Ratio
TENET HEALTHCARE CORP (THC)United States$20.097B
Surgery Partners, Inc. (SGRY)United States$1.860B-24.80
Ardent Health, Inc. (ARDT)United States$1.478B17.91
COMMUNITY HEALTH SYSTEMS INC (CYH)United States$0.405B1.87